![Stephane Depil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Anciens postes connus de Stephane Depil
| Sociétés | Poste | Fin |
|---|---|---|
| CELLECTIS S.A. | Directeur Technique/Scientifique/R&D | 01/02/2019 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Directeur Général | - |
Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Formation de Stephane Depil
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Centre Léon Bérard Lyon et Rhône-Alpes | |
Université de Lille III
 Université de Lille III Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
